PI3K Inhibition for Squamous Cell Head and Neck Carcinoma

被引：5
|
作者：
Desilets, Antoine [1 ,2 ]
Soulieres, Denis [1 ]
机构：
[1] Ctr Hosp Univ Montreal CHUM, Pavillon C,1000 Rue St Denis, Montreal, PQ H2X 0C1, Canada
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
CANCER JOURNAL | 2022年 / 28卷 / 05期
关键词：
Head and neck squamous cell carcinoma; PI3K inhibitors; targeted therapy; PHOSPHOINOSITIDE 3-KINASE INHIBITOR; I DOSE-ESCALATION; BUPARLISIB BKM120; PACLITAXEL; RECURRENT; CHEMOTHERAPY; COMBINATION; EXPRESSION; RECEPTOR; NIVOLUMAB;
D O I：
10.1097/PPO.0000000000000618
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The phosphoinositide 3-kinase (PI3K) pathway is aberrantly activated in most head and neck squamous cell carcinomas, making it a prized target for targeted therapy development. Multiple PI3K inhibitors have been studied in early phase trials, with unfavorable risk-benefit ratios in molecularly unselected patient populations. Buparlisib, a potent pan-class I PI3K inhibitor, shows promising efficacy in combination with paclitaxel for advanced head and neck squamous cell carcinoma. Results of the phase III BURAN trial are awaited.
引用
收藏
页码：369 / 376
页数：8
相关论文
共 50 条
  • [31] HER3 targeting potentiates growth suppressive effects of the PI3K inhibitor BYL719 in pre-clinical models of head and neck squamous cell carcinoma
    Meister, Kara S.
    Godse, Neal R.
    Khan, Nayel, I
    Hedberg, Matthew L.
    Kemp, Carolyn
    Kulkarni, Sucheta
    Alvarado, Diego
    LaVallee, Theresa
    Kim, Seungwon
    Grandis, Jennifer R.
    Duvvuri, Umamaheswar
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [32] Efficacy of chemotherapy after progression with nivolumab in squamous cell carcinoma of the head and neck
    Suzuki, Shinsuke
    Toyoma, Satoshi
    Tomizawa, Hiroki
    Yamada, Toshiki
    Iikawa, Nobuko
    Shiina, Kazuhiro
    Saito, Hidekazu
    Koizumi, Koh
    Kawasaki, Yohei
    Yamada, Takechiyo
    AURIS NASUS LARYNX, 2020, 47 (03) : 485 - 488
  • [33] Nivolumab in squamous cell carcinoma of the head and neck
    Specenier, Pol
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (05) : 409 - 420
  • [34] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Moskovitz, Jessica
    Moy, Jennifer
    Ferris, Robert L.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (02)
  • [35] Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinoma
    Jagadeeshan, Sankar
    Suryamohan, Kushal
    Shin, Nara
    Mathukkada, Sooraj
    Boyko, Alexandra
    Melikhova, Daria
    Tsareva, Anastasia
    Yunusova, Leysan
    Pravdivtseva, Ekaterina
    Stupichev, Danil
    Shaposhnikov, Kirill
    Peterson, Angela
    Bednyagin, Lev
    Shugaev-Mendosa, Eduardo
    Kessler, Linda
    Burrows, Francis
    Ho, Alan L.
    Agrawal, Nishant
    Pearson, Alexander T.
    Izumchenko, Evgeny
    Cole, Grayson
    Elkabets, Moshe
    Rosenberg, Ari J.
    ORAL ONCOLOGY, 2024, 149
  • [36] Oligometastasis in Head and Neck Squamous Cell Carcinoma
    Moon, Dominic H.
    Sher, David J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (04): : 803 - 811
  • [37] Weekly Cetuximab and Paclitaxel for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Fushimi, Chihiro
    Baba, Daisuke
    Masubuchi, Tatsuo
    Yamazaki, Morio
    Kitani, Yosuke
    Kitajima, Tatsuya
    Tanaka, Junpei
    Hanyu, Kenji
    Tanaka, Naruhisa
    Miura, Kouki
    Tada, Yuichiro
    IN VIVO, 2020, 34 (05): : 2653 - 2657
  • [38] In silico discovery of a novel potential allosteric PI3Kα inhibitor incorporating 2-oxopropyl urea targeting head and neck squamous cell carcinoma
    Jia, Wenqing
    Li, Guangzhuang
    Cheng, Xianchao
    Zhang, Ruijie
    Ma, Yukui
    BMC CHEMISTRY, 2025, 19 (01)
  • [39] Livin enhances chemoresistance in head and neck squamous cell carcinoma
    Yoon, Tae Mi
    Kim, Sun-Ae
    Lee, Dong Hoon
    Lee, Joon Kyoo
    Park, Young-Lan
    Lee, Kyung-Hwa
    Chung, Ik-Joo
    Joo, Young-Eun
    Lim, Sang Chul
    ONCOLOGY REPORTS, 2017, 37 (06) : 3667 - 3673
  • [40] Bleeding complications in patients with squamous cell carcinoma of the head and neck
    Bergamini, Cristiana
    Ferris, Robert L.
    Xie, Jing
    Mariani, Gabriella
    Ali, Muzammil
    Holmes, William C.
    Harrington, Kevin
    Psyrri, Amanda
    Cavalieri, Stefano
    Licitra, Lisa
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (09): : 2844 - 2858
12345